ConductScience.org, home

Paper778261

Humoral immunity in experimental syphilis. I. The demonstration of resistance conferred by passive immunization.

Bishop NH and 1 other. J Immunol, 1976. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. Humoral immunity in experimental syphilis. I. The demonstration of resistance conferred by passive immunization. Papers, record 778261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/778261

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Humoral immunity in experimental syphilis. I. The demonstration of resistance conferred by passive immunization.
PubMed
Journal
J Immunol
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
2.68
iCite
Revised in PubMed
2006-11-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bishop NHN H
2Miller JNJ N

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ImmunityMajor topic
Immunity, Maternally-AcquiredMajor topic
SyphilisMajor topic
Animals
Antibodies, Bacterial
Immune Tolerance
Male
Rabbits
Treponema Immobilization Test
Treponema pallidum

Source PubMed

Download CSV of topics

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
42516433The Treponema pallidum outer membrane protein repertoire and the quest for a syphilis vaccine.J Bras Doencas Sex Transm2026https://conductscience.org/library/papers/42516433PubMed
42383911Advancements in Syphilis Vaccine Development.Sex Transm Dis2026https://conductscience.org/library/papers/42383911PubMed
42324733An mRNA-LNP vaccine expressing TP0435 provides protective immunity in rabbits against Treponema pallidum challenge.Emerg Microbes Infect2026https://conductscience.org/library/papers/42324733PubMed
42262076High-throughput profiling of the IgG and IgA response to the Treponema pallidum subsp. pallidum proteome in syphilis patients.mBio2026https://conductscience.org/library/papers/42262076PubMed
41550954Antibodies directed against extracellular loops of FadL orthologs disrupt outer membrane integrity and neutralize infectivity of Treponema pallidum, the syphilis spirochete.Front Immunol2025https://conductscience.org/library/papers/41550954PubMed
41362418The changing epidemiology of syphilis: new strategies for new challenges in China.Lancet Reg Health West Pac2025https://conductscience.org/library/papers/41362418PubMed
39715273Immunodominant extracellular loops of Treponema pallidum FadL outer membrane proteins elicit antibodies with opsonic and growth-inhibitory activities.PLoS Pathog2024https://conductscience.org/library/papers/39715273PubMed
39262771A novel pan-proteome array for high-throughput profiling of the humoral response to Treponema pallidum.iScience2024https://conductscience.org/library/papers/39262771PubMed
39203989Immunity to Sexually Transmitted Bacterial Infections of the Female Genital Tract: Toward Effective Vaccines.Vaccines (Basel)2024https://conductscience.org/library/papers/39203989PubMed
37090699Syphilis vaccine: challenges, controversies and opportunities.Front Immunol2023https://conductscience.org/library/papers/37090699PubMed
27721440Treponema pallidum, the syphilis spirochete: making a living as a stealth pathogen.Nat Rev Microbiol2016https://conductscience.org/library/papers/27721440PubMed
27328030Vaccine development for syphilis.Expert Rev Vaccines2017https://conductscience.org/library/papers/27328030PubMed
24135571Current status of syphilis vaccine development: need, challenges, prospects.Vaccine2014https://conductscience.org/library/papers/24135571PubMed
22133883Syphilis: using modern approaches to understand an old disease.J Clin Invest2011https://conductscience.org/library/papers/22133883PubMed
16418521Biological basis for syphilis.Clin Microbiol Rev2006https://conductscience.org/library/papers/16418521PubMed
16113312Quantitative assessment of protection in experimental syphilis.Infect Immun2005https://conductscience.org/library/papers/16113312PubMed
15845516A monoclonal antibody that conveys in vitro killing and partial protection in experimental syphilis binds a phosphorylcholine surface epitope of Treponema pallidum.Infect Immun2005https://conductscience.org/library/papers/15845516PubMed
14500480Protection against syphilis correlates with specificity of antibodies to the variable regions of Treponema pallidum repeat protein K.Infect Immun2003https://conductscience.org/library/papers/14500480PubMed
12438357Immunization with the N-terminal portion of Treponema pallidum repeat protein K attenuates syphilitic lesion development in the rabbit model.Infect Immun2002https://conductscience.org/library/papers/12438357PubMed
10456928T-Cell responses to Treponema pallidum subsp. pallidum antigens during the course of experimental syphilis infection.Infect Immun1999https://conductscience.org/library/papers/10456928PubMed

See all 58 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/778261

GET https://conductscience.org/api/papers/v1/778261/cited_by?page=2